Telix Pharmaceuticals Ltd. (TLX)
Telix Pharmaceuticals Market Cap: 3.200B for Dec. 9, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Immutep Ltd. | 312.95M |
| Mesoblast Ltd. | 2.439B |
| Alterity Therapeutics Ltd. | 60.00M |
| Kazia Therapeutics Ltd. | 28.58M |
| Propanc Biopharma, Inc. | 10.77M |
Market Cap Related Metrics
| PE Ratio | 308.39 |
| PS Ratio | 4.955 |
| Price to Book Value | 27.07 |
| Price | 9.56 |
| Earnings Yield | 0.32% |
| Operating PE Ratio | 108.91 |
| Normalized PE Ratio | 175.74 |